Does anyone know the expected results date for the phase 3 clinical trials? Or any of the expected key announcement dates over the next 12 months?
OPT website says clinical trials have been initiated (extract below) but I cant find any other information.
"Opthea has completed a Phase 2b clinical trial investigating OPT-302 in wet AMD patients, and has completed a Phase 1b/2a clinical trial in patients with DME. Opthea is planning to initiate two pivotal Phase 3 clinical trials for the treatment of wet AMD in the first half of 2021."
Does anyone know the expected results date for the phase 3...
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.5¢ |
Change
0.015(3.66%) |
Mkt cap ! $529.3M | |||
| Open | High | Low | Value | Volume |
| 42.0¢ | 43.5¢ | 42.0¢ | $244.9K | 578.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 74116 | 42.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.0¢ | 63822 | 10 |
View Market Depth
| Last trade - 11.09am 29/07/2024 (20 minute delay) ? |
| OPT (ASX) Chart |